Laman UtamaEDIT • NASDAQ
add
Editas Medicine Inc
$1.27
Selepas Waktu Dagangan:(0.00%)0.00
$1.27
Tutup: 16 Apr, 4:02:43 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$1.35
Julat hari
$1.25 - $1.34
Julat tahun
$0.91 - $6.69
Permodalan pasaran
105.38J USD
Bilangan Purata
2.47J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | 30.60J | -49.03% |
Perbelanjaan pengendalian | 16.35J | 13.14% |
Pendapatan bersih | -45.40J | -140.52% |
Margin untung bersih | -148.33 | -371.94% |
Pendapatan bagi setiap syer | -0.55 | -139.13% |
EBITDA | -32.98J | -46.60% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 269.91J | -16.46% |
Jumlah aset | 341.59J | -31.57% |
Jumlah liabiliti | 207.32J | 38.16% |
Jumlah ekuiti | 134.27J | — |
Syer tertunggak | 82.98J | — |
Harga kepada buku | 0.83 | — |
Pulangan pada aset | -25.67% | — |
Pulangan pada modal | -44.81% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -45.40J | -140.52% |
Tunai daripada operasi | -50.76J | -128.25% |
Tunai daripada pelaburan | 30.96J | -50.74% |
Tunai daripada pembiayaan | 55.51J | 10,700.19% |
Perubahan bersih dalam tunai | 35.71J | -13.15% |
Aliran tunai bebas | -23.35J | -45.40% |
Perihal
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Diasaskan
Nov 2013
Tapak web
Pekerja
246
